Fundz

Matchpoint Therapeutics reported raising $42 Million in an initial SEC Form D filing, from an offering of $70 Million

PRIVATEOct 17, 2022$42M of $70M raised

Amount Raised

$42 Million

$42 Million sold, per SEC Form D (first sale Oct 5, 2022)

Round Type

Venture

CambridgeHealthcare

Quick answer

Matchpoint Therapeutics raised $42 Million in a funding round, dated October 5, 2022. Matchpoint Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Matchpoint Therapeutics raise?
Matchpoint Therapeutics raised $42 Million in a funding round on October 5, 2022.
What does Matchpoint Therapeutics do?
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses.
Where is Matchpoint Therapeutics based and how big is it?
Matchpoint Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 32 employees.
Who are the decision-makers at Matchpoint Therapeutics?
Fundz holds 1 contact at Matchpoint Therapeutics, including the Senior Vice President, Head of Platform and Chemical Biology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Matchpoint Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Venus Concept Inc. raised $6.7M on November 18, 2022.
  • Laguna Tech USA raised $5M on November 18, 2022.
  • SCA Health raised $18K (Pre-Seed) on November 18, 2022.
  • Streamex Corp. raised $1.5M (Seed) on November 18, 2022.
  • Ingenia Therapeutics raised $7M on November 18, 2022.
  • Gate Science raised $150K (Seed) on November 18, 2022.

Who to call at Matchpoint Therapeutics, and when

A new round usually means Matchpoint Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Matchpoint Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Matchpoint Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Matchpoint Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Matchpoint Therapeutics

Location

ONE KENDALL SQUARE

Cambridge, Massachusetts, United States

About

Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines initially focused on immunology. For more information, please visit www.matchpointtx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Matchpoint Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPaola C., Senior Vice President, Head of Platform… hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Matchpoint Therapeutics's next move

See what Strategic adds

Matchpoint Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.